• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Novel insights into cholesterol regulation may lead to new therapies for heart disease

Bioengineer by Bioengineer
June 4, 2019
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Long-term goals hold promise for treatment of blood disorders and bone marrow regeneration

IMAGE

Credit: Houston Methodist

In a landmark study, scientists at Houston Methodist Research Institute discovered what makes white blood cell counts spike in individuals who have high cholesterol, possibly leading to new therapies for heart disease.

Led by Longhou Fang, Ph.D., an associate professor in the Center for Cardiovascular Regeneration, and his postdoctoral fellow Qilin Gu, Ph.D., the team looked at hypercholesterolemia, which is the type of high cholesterol that causes very high levels of LDL – the so-called “bad” cholesterol – to circulate in the blood.

They identified a new regulatory mechanism in zebrafish models responsible for this increase in white blood cells typically seen in people with these high LDL levels, which are known to increase a person’s risk for cardiovascular disease, the leading cause of morbidity and mortality in the U.S. and globally.

“Our findings may explain why this can happen,” Fang said. “This mechanism we identified activates a protein called SREBP2 that in turn leads to the development of more hematopoietic stem cells (HSPCs), which are the precursors to white blood cells and the process by which all mature blood cells are produced. We were able to show that targeting this protein using its antagonist can reduce the HSPC counts to bring down the white blood cell counts. This insight may lead to a new strategy to treat atherosclerotic cardiovascular disease.”

Additionally, Fang says finding this new pathway that controls the generation of HSPCs could be useful for treating blood disorders, such as leukemia and anemia, in the future. For instance, he says the plant-derived drug betulin, which is an SREBP2 inhibitor, could possibly be repurposed to mitigate the progression of leukemia. Even further down the line, he said this also holds promise for bone marrow regeneration using patient-derived hematopoietic stem cells, which would eliminate the need to find a donor.

Initially reported in an article titled “AIBP-mediated cholesterol efflux instructs hematopoietic stem and progenitor cell fate” in the journal Science, the study has since been cited by the New England Journal of Medicine (NEJM) and Nature Reviews Cardiology.

In the NEJM editorial, the authors write, “This study certainly teaches us that cholesterol metabolism and inflammation are interconnected in the bone marrow environment through the transcription factor SREBP2.” They go on to say, “The most notable aspect of the study…is the implication of ‘cholesterol metabolism’ genes in the biologic makeup of HSPCs. These findings provide support for the hypothesis that cholesterol metabolism is a driver of inflammation in cardiovascular disease.”

Fang and his colleagues say their next steps are to continue exploring the role of cholesterol metabolism in hematopoiesis, saying that their findings bring them one step closer to their ultimate goal of generating patient-oriented HSPCs, which will be essential for the progress of regenerative and precision medicine.

###

Other researchers collaborating with Fang and Gu on this paper include Xiaojie Yang, Jie Lv, Bo Xia, Jiaxiong Zhang, Jun-dae Kim, Shu Meng, John P. Cooke and Kaifu Chen from Houston Methodist; Yongping Bai from Xiangya Hospital at Central South University in China; Ruoyu Wang, Feng Xiong, Wenbo Li, Miguel F. Diaz and Pamela L. Wenzel from UTHealth; Thomas P. Clements, Bhavna Tandon and Daniel S. Wagner from Rice University; Yury I. Miller and David Traver from University of California San Diego; and Leonard I. Zon from Harvard Medical School.

The work was supported by grants from the National Heart, Lung and Blood Institute (HL114734, HL132155, HL135737, HL133254), the American Heart Association (16BGIA27790081, 18TPA34250009, 17POST33410671), the National Institutes of Health (HL04880, DK49216, K01DK092365, R01DK111599, CA204468, GM125632) and the Cancer Prevention and Research Institute of Texas (RP110776, RR160083, RP120348, RP170002).

For more information about Houston Methodist, visit houstonmethodist.org. Follow us on Twitter and Facebook.

For more information: AIBP-mediated cholesterol efflux instructs hematopoietic stem and progenitor cell fate. Science. (March 8, 2019) Q. Gu, X. Yang, J. Lv, J. Zhang, B. Xia, J. Kim, R. Wang, F. Xiong, S. Meng, T.P. Clements, B. Tandon, D.S. Wagner, M.F. Diaz, P.L. Wenzel, Y.I. Miller, D. Traver, J.P. Cooke, W. Li, L.I. Zon, K. Chen, Y. Bai, L. Fang. DOI: https://doi.org/10.1126/science.aav1749

Media Contact
Lisa Merkl
[email protected]

Related Journal Article

http://dx.doi.org/10.1126/science.aav1749

Tags: BiologyCardiologyCell BiologyCholesterolDevelopmental/Reproductive BiologyHematologyMedicine/HealthMolecular BiologyStroke
Share13Tweet8Share2ShareShareShare2

Related Posts

blank

CK2–PRC2 Signal Drives Plant Cold Memory Epigenetics

August 2, 2025
blank

AI-Driven Protein Design Advances T-Cell Immunotherapy Breakthroughs

August 1, 2025

Melanthiaceae Genomes Reveal Giant Genome Evolution Secrets

August 1, 2025

“Shore Wars: New Study Tackles Oyster-Mangrove Conflicts to Boost Coastal Restoration”

August 1, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    40 shares
    Share 16 Tweet 10
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Predicting Lung Infections After Brain Hemorrhage

Impact of Morphology and Location on Aneurysms

Unraveling EMT’s Role in Colorectal Cancer Spread

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.